- ‘Really, Really Messed Up My Life’
- Quick Start to Healthy Weight Loss
- Black Men Can Beat Prostate Cancer
- Health Screenings for Older Black Men
- Healthy Man of the Month for July 2016
- HIV Testing is HIV Prevention
- Your ‘Mental’ Endurance
- Bisexual Health Priorities
- Entertainment CEO DonJuan Clark
- New Drug Helps Men with Melanoma
Truth About Truvada
A recognized panel of experts recommended US regulators approve the daily pill, Truvada, for use by people considered at high risk of contracting the Aids virus. But the US Food and Drug Administration (FDA) is not required to follow the panel’s advice, but it usually does. TRUVADA is a combination of 2 NRTIs (2-NRTI). TRUVADA is for use in combination with other HIV-1 medicines to treat HIV-1 infection in adults.
Some health workers and groups active in the HIV community have opposed the approval of the drug. There are lots of reasons. Consider the behavioral risks people may take if they feel protected by a pill or the potential for drug resistance in patients. There is also concern that the high cost of Truvada could divert limited funding from more cost-effective options.
Truvada is already approved by the FDA for people who are HIV-positive, and is taken along with existing anti-retroviral drugs. Studies from 2010 showed that Truvada, made by California-based Gilead Sciences, reduced the risk of HIV in healthy gay men – and among HIV-negative heterosexual partners of people who are HIV-positive – by between 44% and 73%.